Phase 1b study of avelumab in advanced previously treated mesothelioma: long-term follow-up from JAVELIN Solid Tumor.

8563Background: Avelumab, a human anti-PD-L1 IgG1 antibody, is approved for treatment of metastatic Merkel cell carcinoma in various countries and advanced urothelial carcinoma progressed on platin...